State Street Investment Management · 2006-01-31 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$1.27B | — | — | $9.73B | 每日估算 |
| 2026-07-30 | +$134.0M | — | — | $10.73B | 每日估算 |
| 2026-07-29 | +$57.7M | — | — | $10.73B | 每日估算 |
| 2026-07-28 | +$304.1M | — | — | $10.73B | 每日估算 |
| 2026-07-27 | +$119.8M | — | — | $10.42B |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
State Street Navigator Securities Lending Portfolio II State Street Navigator Securities Lending Portfolio II | STIV | 595,460,501 | $595.5M | 8.01% |
Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc | EC | 3,390,454 | $136.4M | 1.83% |
Alkermes PLC Alkermes PLC | EC | 3,050,830 | $107.9M | 1.45% |
Madrigal Pharmaceuticals Inc |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、nasdaq_etf_summary、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | +$119.8M | — | — | $10.42B | 每日估算 |
| 2026-03-31 | -$589.5M | $2.86B | $3.45B | $7.43B | SEC 月度 |
| 2026-02-28 | -$443.2M | $2.70B | $3.14B | — | SEC 月度 |
| 2026-01-31 | +$307.4M | $2.64B | $2.34B | — | SEC 月度 |
| EC |
| 196,408 |
| $102.8M |
| 1.38% |
TG Therapeutics Inc TG Therapeutics Inc | EC | 3,020,301 | $100.3M | 1.35% |
Insmed Inc Insmed Inc | EC | 607,845 | $99.4M | 1.34% |
Scholar Rock Holding Corp Scholar Rock Holding Corp | EC | 1,961,965 | $96.5M | 1.30% |
Apogee Therapeutics Inc Apogee Therapeutics Inc | EC | 1,134,394 | $95.5M | 1.28% |
Protagonist Therapeutics Inc Protagonist Therapeutics Inc | EC | 878,071 | $92.5M | 1.24% |
Summit Therapeutics Inc Summit Therapeutics Inc | EC | 4,866,448 | $92.3M | 1.24% |
United Therapeutics Corp United Therapeutics Corp | EC | 155,530 | $92.2M | 1.24% |
Praxis Precision Medicines Inc Praxis Precision Medicines Inc | EC | 285,252 | $91.9M | 1.24% |
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc | EC | 1,458,207 | $91.4M | 1.23% |
Cogent Biosciences Inc Cogent Biosciences Inc | EC | 2,348,101 | $90.4M | 1.22% |
Bridgebio Pharma Inc Bridgebio Pharma Inc | EC | 1,186,816 | $88.1M | 1.19% |
PTC Therapeutics Inc PTC Therapeutics Inc | EC | 1,290,071 | $87.9M | 1.18% |
Cytokinetics Inc Cytokinetics Inc | EC | 1,331,453 | $87.8M | 1.18% |
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc | EC | 264,406 | $87.5M | 1.18% |
Exelixis Inc Exelixis Inc | EC | 2,029,215 | $87.0M | 1.17% |
Nuvalent Inc Nuvalent Inc | EC | 846,768 | $86.8M | 1.17% |
Kymera Therapeutics Inc Kymera Therapeutics Inc | EC | 1,039,280 | $86.6M | 1.16% |
CG oncology Inc CG oncology Inc | EC | 1,276,920 | $86.4M | 1.16% |
Natera Inc Natera Inc | EC | 430,933 | $86.2M | 1.16% |
Neurocrine Biosciences Inc Neurocrine Biosciences Inc | EC | 654,044 | $86.2M | 1.16% |
Twist Bioscience Corp Twist Bioscience Corp | EC | 1,808,036 | $85.9M | 1.16% |
Krystal Biotech Inc Krystal Biotech Inc | EC | 332,277 | $85.8M | 1.15% |
Vaxcyte Inc Vaxcyte Inc | EC | 1,472,715 | $85.6M | 1.15% |
Mirum Pharmaceuticals Inc Mirum Pharmaceuticals Inc | EC | 923,473 | $85.3M | 1.15% |
Amicus Therapeutics Inc Amicus Therapeutics Inc | EC | 5,895,670 | $85.3M | 1.15% |
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc | EC | 1,132,906 | $85.1M | 1.14% |
Travere Therapeutics Inc Travere Therapeutics Inc | EC | 2,863,192 | $85.1M | 1.14% |
Arcellx Inc Arcellx Inc | EC | 740,785 | $85.1M | 1.14% |
Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc | EC | 109,400 | $84.5M | 1.14% |
Incyte Corp Incyte Corp | EC | 895,013 | $84.2M | 1.13% |
Celcuity Inc Celcuity Inc | EC | 731,925 | $83.5M | 1.12% |
Revolution Medicines Inc Revolution Medicines Inc | EC | 850,768 | $82.7M | 1.11% |
Halozyme Therapeutics Inc Halozyme Therapeutics Inc | EC | 1,274,489 | $82.4M | 1.11% |
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc | EC | 941,162 | $81.9M | 1.10% |
Biogen Inc Biogen Inc | EC | 444,855 | $81.6M | 1.10% |
Arcutis Biotherapeutics Inc Arcutis Biotherapeutics Inc | EC | 3,437,805 | $81.0M | 1.09% |
AbbVie Inc AbbVie Inc | EC | 372,103 | $80.9M | 1.09% |
Gilead Sciences Inc Gilead Sciences Inc | EC | 580,264 | $80.9M | 1.09% |
CRISPR Therapeutics AG CRISPR Therapeutics AG | EC | 1,696,801 | $80.7M | 1.09% |
BioMarin Pharmaceutical Inc BioMarin Pharmaceutical Inc | EC | 1,404,601 | $79.3M | 1.07% |
Roivant Sciences Ltd Roivant Sciences Ltd | EC | 2,864,237 | $79.3M | 1.07% |
Amgen Inc Amgen Inc | EC | 224,546 | $79.0M | 1.06% |
ImmunityBio Inc ImmunityBio Inc | EC | 10,244,025 | $78.6M | 1.06% |
Beam Therapeutics Inc Beam Therapeutics Inc | EC | 3,248,626 | $77.4M | 1.04% |
Viking Therapeutics Inc Viking Therapeutics Inc | EC | 2,369,189 | $77.1M | 1.04% |
Vera Therapeutics Inc Vera Therapeutics Inc | EC | 1,912,054 | $76.9M | 1.03% |
Moderna Inc Moderna Inc | EC | 1,513,720 | $76.9M | 1.03% |
Vertex Pharmaceuticals Inc Vertex Pharmaceuticals Inc | EC | 172,078 | $76.8M | 1.03% |
Erasca Inc Erasca Inc | EC | 4,733,094 | $76.6M | 1.03% |
ACADIA Pharmaceuticals Inc ACADIA Pharmaceuticals Inc | EC | 3,412,655 | $76.0M | 1.02% |
Sarepta Therapeutics Inc Sarepta Therapeutics Inc | EC | 3,057,030 | $66.5M | 0.89% |
Agios Pharmaceuticals Inc Agios Pharmaceuticals Inc | EC | 1,930,324 | $65.3M | 0.88% |
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc | EC | 3,107,837 | $65.1M | 0.88% |
Disc Medicine Inc Disc Medicine Inc | EC | 1,012,048 | $64.7M | 0.87% |
Immunome Inc Immunome Inc | EC | 2,934,802 | $64.2M | 0.86% |
Immunovant Inc Immunovant Inc | EC | 2,566,528 | $63.8M | 0.86% |
BioCryst Pharmaceuticals Inc BioCryst Pharmaceuticals Inc | EC | 6,655,054 | $63.4M | 0.85% |
Veracyte Inc Veracyte Inc | EC | 1,957,681 | $63.1M | 0.85% |
Dyne Therapeutics Inc Dyne Therapeutics Inc | EC | 3,437,524 | $62.3M | 0.84% |
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc | EC | 2,268,292 | $56.2M | 0.76% |
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc | EC | 2,343,191 | $54.7M | 0.74% |
Denali Therapeutics Inc Denali Therapeutics Inc | EC | 2,830,854 | $54.4M | 0.73% |
Ideaya Biosciences Inc Ideaya Biosciences Inc | EC | 1,628,726 | $54.3M | 0.73% |
Spyre Therapeutics Inc Spyre Therapeutics Inc | EC | 1,069,556 | $53.9M | 0.73% |
GRAIL Inc GRAIL Inc | EC | 1,041,295 | $53.8M | 0.72% |
Viridian Therapeutics Inc Viridian Therapeutics Inc | EC | 2,667,007 | $52.2M | 0.70% |
Recursion Pharmaceuticals Inc Recursion Pharmaceuticals Inc | EC | 16,732,511 | $51.4M | 0.69% |
Kodiak Sciences Inc Kodiak Sciences Inc | EC | 1,344,151 | $51.2M | 0.69% |
Soleno Therapeutics Inc Soleno Therapeutics Inc | EC | 1,496,078 | $50.1M | 0.67% |
Dianthus Therapeutics Inc Dianthus Therapeutics Inc | EC | 586,673 | $49.2M | 0.66% |
Intellia Therapeutics Inc Intellia Therapeutics Inc | EC | 3,753,333 | $48.1M | 0.65% |
Mineralys Therapeutics Inc Mineralys Therapeutics Inc | EC | 1,773,248 | $48.0M | 0.65% |
Arcus Biosciences Inc Arcus Biosciences Inc | EC | 2,163,363 | $46.7M | 0.63% |
Ardelyx Inc Ardelyx Inc | EC | 7,664,448 | $45.9M | 0.62% |
ADMA Biologics Inc ADMA Biologics Inc | EC | 4,916,092 | $44.3M | 0.60% |
Nurix Therapeutics Inc Nurix Therapeutics Inc | EC | 2,809,877 | $43.6M | 0.59% |
Tango Therapeutics Inc Tango Therapeutics Inc | EC | 1,972,571 | $41.3M | 0.56% |
Celldex Therapeutics Inc Celldex Therapeutics Inc | EC | 1,222,480 | $38.8M | 0.52% |
Novavax Inc Novavax Inc | EC | 4,667,715 | $38.0M | 0.51% |
Oruka Therapeutics Inc Oruka Therapeutics Inc | EC | 761,033 | $37.3M | 0.50% |
Olema Pharmaceuticals Inc Olema Pharmaceuticals Inc | EC | 2,471,879 | $36.9M | 0.50% |
Stoke Therapeutics Inc Stoke Therapeutics Inc | EC | 1,125,672 | $36.7M | 0.49% |
Vericel Corp Vericel Corp | EC | 1,116,252 | $35.9M | 0.48% |
Capricor Therapeutics Inc Capricor Therapeutics Inc | EC | 1,171,894 | $35.6M | 0.48% |
Palvella Therapeutics Inc Palvella Therapeutics Inc | EC | 274,232 | $34.2M | 0.46% |
Biohaven Ltd Biohaven Ltd | EC | 3,844,682 | $32.5M | 0.44% |
Monte Rosa Therapeutics Inc Monte Rosa Therapeutics Inc | EC | 1,966,731 | $32.4M | 0.44% |
Corvus Pharmaceuticals Inc Corvus Pharmaceuticals Inc | EC | 2,116,858 | $31.0M | 0.42% |
Iovance Biotherapeutics Inc Iovance Biotherapeutics Inc | EC | 8,139,873 | $28.6M | 0.38% |
AnaptysBio Inc AnaptysBio Inc | EC | 512,175 | $28.4M | 0.38% |
Relay Therapeutics Inc Relay Therapeutics Inc | EC | 2,831,639 | $28.2M | 0.38% |
uniQure NV uniQure NV | EC | 1,697,402 | $27.8M | 0.37% |
ORIC Pharmaceuticals Inc ORIC Pharmaceuticals Inc | EC | 2,171,512 | $27.5M | 0.37% |
MannKind Corp MannKind Corp | EC | 10,933,657 | $26.8M | 0.36% |
CareDx Inc CareDx Inc | EC | 1,480,419 | $25.7M | 0.35% |
Taysha Gene Therapies Inc Taysha Gene Therapies Inc | EC | 5,638,911 | $25.2M | 0.34% |
Tyra Biosciences Inc Tyra Biosciences Inc | EC | 655,457 | $25.1M | 0.34% |
Geron Corp Geron Corp | EC | 16,613,693 | $24.8M | 0.33% |
Day One Biopharmaceuticals Inc Day One Biopharmaceuticals Inc | EC | 1,113,401 | $23.9M | 0.32% |
Precigen Inc Precigen Inc | EC | 6,004,794 | $23.2M | 0.31% |
Vir Biotechnology Inc Vir Biotechnology Inc | EC | 2,527,795 | $22.6M | 0.30% |
KalVista Pharmaceuticals Inc KalVista Pharmaceuticals Inc | EC | 1,077,952 | $21.7M | 0.29% |
CytomX Therapeutics Inc CytomX Therapeutics Inc | EC | 4,511,036 | $21.2M | 0.29% |
Annexon Inc Annexon Inc | EC | 3,823,368 | $21.2M | 0.28% |
Kura Oncology Inc Kura Oncology Inc | EC | 2,523,230 | $20.5M | 0.28% |
Inhibrx Biosciences Inc Inhibrx Biosciences Inc | EC | 296,581 | $19.9M | 0.27% |
SELLAS Life Sciences Group Inc SELLAS Life Sciences Group Inc | EC | 4,689,810 | $19.8M | 0.27% |
Janux Therapeutics Inc Janux Therapeutics Inc | EC | 1,424,540 | $19.8M | 0.27% |
Compass Therapeutics Inc Compass Therapeutics Inc | EC | 3,684,989 | $19.5M | 0.26% |
Savara Inc Savara Inc | EC | 3,554,970 | $19.4M | 0.26% |
Rigel Pharmaceuticals Inc Rigel Pharmaceuticals Inc | EC | 708,776 | $19.2M | 0.26% |
Sana Biotechnology Inc Sana Biotechnology Inc | EC | 6,650,475 | $19.2M | 0.26% |
Cullinan Therapeutics Inc Cullinan Therapeutics Inc | EC | 1,307,461 | $18.6M | 0.25% |
ARS Pharmaceuticals Inc ARS Pharmaceuticals Inc | EC | 2,213,506 | $17.8M | 0.24% |
Zenas Biopharma Inc Zenas Biopharma Inc | EC | 906,255 | $17.7M | 0.24% |
Xencor Inc Xencor Inc | EC | 1,422,163 | $17.2M | 0.23% |
Replimune Group Inc Replimune Group Inc | EC | 2,198,386 | $16.8M | 0.23% |
Sionna Therapeutics Inc Sionna Therapeutics Inc | EC | 416,630 | $16.7M | 0.22% |
Vor BioPharma Inc Vor BioPharma Inc | EC | 932,400 | $16.6M | 0.22% |
ArriVent Biopharma Inc ArriVent Biopharma Inc | EC | 701,088 | $16.2M | 0.22% |
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc | EC | 3,999,224 | $14.0M | 0.19% |
Bicara Therapeutics Inc Bicara Therapeutics Inc | EC | 701,643 | $14.0M | 0.19% |
Prime Medicine Inc Prime Medicine Inc | EC | 3,979,993 | $13.9M | 0.19% |
Altimmune Inc Altimmune Inc | EC | 4,353,091 | $13.4M | 0.18% |
Absci Corp Absci Corp | EC | 4,448,453 | $13.3M | 0.18% |
Emergent BioSolutions Inc Emergent BioSolutions Inc | EC | 1,572,925 | $13.1M | 0.18% |
Allogene Therapeutics Inc Allogene Therapeutics Inc | EC | 5,212,606 | $12.7M | 0.17% |
Hyperliquid Strategies Inc Hyperliquid Strategies Inc | EC | 2,451,336 | $12.5M | 0.17% |
4D Molecular Therapeutics Inc 4D Molecular Therapeutics Inc | EC | 1,318,068 | $12.3M | 0.17% |
Vanda Pharmaceuticals Inc Vanda Pharmaceuticals Inc | EC | 1,704,031 | $11.8M | 0.16% |
REGENXBIO Inc REGENXBIO Inc | EC | 1,363,810 | $11.4M | 0.15% |
Lexeo Therapeutics Inc Lexeo Therapeutics Inc | EC | 1,862,707 | $10.7M | 0.14% |
Verastem Inc Verastem Inc | EC | 2,014,499 | $10.7M | 0.14% |
Arbutus Biopharma Corp Arbutus Biopharma Corp | EC | 2,268,065 | $10.2M | 0.14% |
Myriad Genetics Inc Myriad Genetics Inc | EC | 2,160,321 | $9.7M | 0.13% |
Prothena Corp PLC Prothena Corp PLC | EC | 983,448 | $9.6M | 0.13% |
Ocugen Inc Ocugen Inc | EC | 5,222,819 | $9.5M | 0.13% |
Rocket Pharmaceuticals Inc Rocket Pharmaceuticals Inc | EC | 2,606,982 | $9.3M | 0.13% |
MiMedx Group Inc MiMedx Group Inc | EC | 2,282,660 | $9.0M | 0.12% |
Akebia Therapeutics Inc Akebia Therapeutics Inc | EC | 6,038,997 | $8.4M | 0.11% |
Anavex Life Sciences Corp Anavex Life Sciences Corp | EC | 2,653,883 | $8.1M | 0.11% |
CONTRA METSERA INC CONTRA METSERA INC | DE | 1,530,714 | $7.5M | 0.10% |
Invivyd Inc Invivyd Inc | EC | 5,654,625 | $7.4M | 0.10% |
Perspective Therapeutics Inc Perspective Therapeutics Inc | EC | 1,713,495 | $7.1M | 0.10% |
State Street Institutional US Government Money Market Fund State Street Institutional US Government Money Market Fund | STIV | 4,700,194 | $4.7M | 0.06% |
Damora Therapeutics Inc Damora Therapeutics Inc | EC | 93,797 | $2.4M | 0.03% |
CONTRA AKERO THERAPEUT CONTRA AKERO THERAPEUT | DE | 2,033,975 | $1.3M | 0.02% |
CONTRA INHIBRX INC CONTRA INHIBRX INC | DE | 1,645,973 | $1.1M | 0.01% |
CONTRA MIRATI THERAPEU CONTRA MIRATI THERAPEU | DE | 1,369,552 | $958,686 | 0.01% |
CONTRA VERVE THERAPEUT CONTRA VERVE THERAPEUT | DE | 900,273 | $567,172 | 0.01% |
CONTRA BLUEPRINT MEDIC CONTRA BLUEPRINT MEDIC | DE | 756,469 | $347,976 | 0.00% |
State Street Institutional US Government Money Market Fund State Street Institutional US Government Money Market Fund | STIV | 36,551 | $36,551 | 0.00% |
OMNIAB INC OMNIAB INC | EC | 161,959 | $0 | 0.00% |
OMNIAB INC OMNIAB INC | EC | 161,959 | $0 | 0.00% |